Join the Oncology Voice Network. Join for Free
From Clinical to Medical Device MSL and Beyond
Medical Science Liaison MSL roles medical device industry transitioning MSL International MSL Day

From Clinical to Medical Device MSL and Beyond


Share This Article


Summary

In this episode, Maria Abunto joins Tom Caravela to discuss her journey from clinical practice to becoming a successful Medical Science Liaison (MSL) in the medical device industry. Maria shares insights on why clinicians are well-suited for MSL roles and the importance of mentors and career coaches. The conversation delves into transitioning within MSL roles, adapting to the pandemic's impact, and the evolving future of MSL work. Maria offers valuable advice for aspiring MSLs, touching on changes in metrics and KPIs. The episode concludes with a celebration of International MSL Day and a call for listener feedback.

Check out my latest podcast with Maria Abunto, Medical Science Liaison at Exact Sciences who discusses her path from clinician to a Medical Device MSL and beyond.

Maria shares….

 What is a Medical Device MSL
 How are Med Device MSLs different than therapeutic MSLs
 Why is it so important to be organized for territory excellence
 Advice for MSLs now and for the future

Click for Source
Medical Science Liaison, MSL roles, medical device industry, transitioning MSL, International MSL Day

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
OVN Avatar Omer Ben‐Aharon, Racheli Magnezi, Moshe Leshno, and Daniel A. Goldstein

Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?

Press Release
Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes
OVN Avatar OVN Staff

Announcing the Launch of Voices of Oncology: A Landmark Collaboration with Forbes

Press Release
Introducing OncologyVoiceNetwork.com
OVN Avatar OVN Staff

Introducing OncologyVoiceNetwork.com

Article
Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020
OVN Avatar A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Explore OVN